World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc
Journal website http://www.wjon.org

Case Report

Volume 2, Number 4, August 2011, pages 204-207


Spontaneous Tumor Lysis Syndrome in Metastatic Melanoma

Figure

Figure 1.
Figure 1. Biochemical parameters within the last 24 hours prior to death. K: potassium (mmol/dL); Ca: calcium (mg/dL); phos: phosphorrus (mg/dL); UA: uric acid (mg/dL); HD: hemodialysis.

Table

Table 1. Characteristics of Tumor Lysis Syndrome (TLS) in Metastatic Melanoma
 
ReferenceAge, sexPrimary siteMetastatic lesionsTriggerOnset of TLSHemodialysisOutcomes
TNF- α, tumor necrosis factor; IL-2, interleukin-2; IFN-α, interferon-α; NS, not stated.
276, MNSLiver, lung, spleen, pelvis, lymph nodesIFN-α, anti-GD3 ganglioside monoclonal antibody8 hNot requiredDied
361, MAbdomenLiver, lung, axillary lymph nodeIL-2, IFN-α, cisplatin, dacarbazine, vinblastine24 hNot requiredDied
441, MNSLiver, GI tractTNF-α, cisplatin, dacarbazine2 daysInitiated, but discontinued at patient’s own request in a weekNS
556, FShoulderLiver, lung, boneHydrocortisone7 hNot requiredDied
636, FBackLiver, lungIL-2, IFN-α, cisplatin, dacarbazine, vinblastine3 daysInitiated with improvement of renal dysfunctionDied
762, MChoroidLiverTranscatheter arterial infusion of cisplatin and embolization24 hInitiated with improvement of renal dysfunctionDied
842, MNSLiver, spleen, bone, Abdominal lymph nodesCorticosteroid2 daysNSDied
This case46, MAbdomen wallLiver, spleen, lymph nodeNoSpontaneousRequiredDied